socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Thursday, December 8, 2005

    Ambrx, Roche In Technology Deal
    Roche and San Diego-based Ambrx today announced that the two companies have entered into a collaboration to develop next generation proteins and peptides using Ambrx technology. Roche will fund research and development of the products, and retain worldwide commercialization rights. Ambrx will receive license fees and royalties on product sales. Roche Venture Fund will also make an equity investment in Ambrx as part of the deal. Ambrx is backed by 5AM Ventures, Tavistock, Versant Ventures, CMEA, Aravis Ventures, and others. Ambrx genetically engineers proteins using amino acid building blocks.
    posted on Thursday, December 8, 2005 (Link to more information)

    Related companies:
    Ambrx

    Related stories:
    > Ambrx Raises $52M
    > Ambrx Expands Series C
    > Ambrx Raises $23.4M
    > Syrrx Inks $178M Deal With Roche
    > Sequenom Hires R&D Head

    RSS subscri be via emailEmail


    Previous news:

     Friday, October 10, 2008
    Tuesday, October 7, 2008
    Monday, October 6, 2008
    Friday, October 3, 2008
    Thursday, October 2, 2008